Cisplatin with high-dose infusions of hydroxyurea to inhibit DNA repair-Reference-Cited by-同舟云学术

Cisplatin with high-dose infusions of hydroxyurea to inhibit DNA repair

Published:1989 Issue:4 Volume:23 Page:252-254
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother. Pharmacol.

Author:

Cantwell Brian M. J.,Veale Daniel,Rivett Christine,Ghani Sarah,Harris Adrian L.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00451651.pdf

Reference19 articles.

1. Bakowski MT, Crouch JC (1983) Chemotherapy of non-small-cell lung cancer: a reappraisal and a look to the future. Cancer Treat Rev 10: 159?172

2. Belt RJ, Hass CD, Kennedy J, Taylor S (1980) Studies of hydroxyurea administered by continuous infusion. Cancer 46: 455?462

3. Bickers JN (1964) Phase II studies of hydroxyurea (NSC-32065) in adults: carcinoma of the lung. Cancer Chemother Rep 40: 45?46

4. Elford HL (1968) Effect of hydroxyurea on ribonucleotide reductase. Biochem Biophys Res Commun 33: 129?135

5. Laurent G, Erickson LC, Sharkey NA, Kohn KW (1981) DNA cross-linking and cytotoxicity induced by cis-diammine dichloroplatinum(II) in human normal and tumour cell lines. Cancer Res 41: 3347?3351

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thermodynamic insights into interaction of protein coated gold nanoclusters with DNA and influence of coating on drug binding;Journal of Molecular Liquids;2019-06

2. Hydroxyurea: a key player in cancer chemotherapy;Expert Review of Anticancer Therapy;2012-01

3. Cellular pharmacodynamics and plasma pharmacokinetics of parenterally infused hydroxyurea during a phase I clinical trial in chronic myelogenous leukemia.;Journal of Clinical Oncology;1998-07

4. A phase I trial of high-dose continuous-infusion hydroxyurea;Cancer Chemotherapy and Pharmacology;1993

5. Concomitant Chemoradiotherapy With Cisplatin, 5-Fluorouracil and Hydroxyurea in Poor-Prognosis Head and Neck Cancer;The Laryngoscope;1992-06